IP Library › Assignment 035866/0477
Patent Assignment
Reel/Frame 035866/0477

Merger

Recorded: 2015-06-19 Pages: 5
Assignor
ALEXION CAMBRIDGE CORPORATION
Executed: 2014-11-25
Assignee
ALEXION PHARMACEUTICALS, INC.
352 KNOTTER DRIVE, CHESHIRE, CONNECTICUT, 06410
Covered Properties (6)
Humaneered Anti-Factor B Antibody
Patent: 7,964,705 →
Application: 12/049,233 →
Publication: US 2008/0299114
Humaneered Anti-Factor B Antibody
Application: 13/115,810 →
Publication: US 2011/0318337
Treatment of Paroxysmal Nocturnal Hemoglobinuria, Hemolytic Anemias and Disease States Involving Intravascular and Extravascular Hemolysis
Application: 13/505,150 →
Publication: US 2013/0029912
Humaneered Anti-Factor B Antibody
Patent: 9,096,677 →
Application: 13/722,071 →
Publication: US 2013/0216529
Humaneered anti-factor B antibody
Application: 60/906,816 →
Treatment of paroxysmal nocturnal hemoglobinuria and disease states involving intravascular and extravascular hemolysis
Application: 61/280,567 →
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 8, 2007
From: EMLEN, WOODRUFF; HOLERS, MICHAEL
To: TALIGEN THERAPEUTICS
Reel/Frame 019665/0273 →
Assignment of Assignor's Interest Jul 9, 2008
From: EMLEN, WOODRUFF; HOLERS, V. MICHAEL; FLYNN, PETER
To: TALIGEN THERAPEUTICS, INC.
Reel/Frame 021215/0595 →
Assignment of Assignor's Interest Jan 27, 2011
From: HOLERS, V. MICHAEL
To: TALIGEN THERAPEUTICS, INC.
Reel/Frame 025709/0001 →
Assignment of Assignor's Interest Dec 12, 2012
From: EMLEN, WOODRUFF; HOLERS, V. MICHAEL; FLYNN, PETER
To: TALIGEN THERAPEUTICS, INC.
Reel/Frame 029454/0711 →
Change of Name Dec 12, 2012
From: TALIGEN THERAPEUTICS, INC.
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029454/0515 →
Change of Address Feb 12, 2013
From: ALEXION CAMBRIDGE CORPORATION
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029801/0586 →
Assignment of Assignor's Interest Feb 12, 2013
From: EMLEN, WOODRUFF; HOLERS, V. MICHAEL; FLYNN, PETER
To: TALIGEN THERAPEUTICS, INC.
Reel/Frame 029799/0771 →
Change of Name Feb 12, 2013
From: TALIGEN THERAPEUTICS, INC.
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029799/0958 →
Assignment of Assignor's Interest Feb 13, 2013
From: HOLERS, V. MICHAEL
To: TALIGEN THERAPEUTICS, INC.
Reel/Frame 029806/0659 →
Change of Name Feb 13, 2013
From: TALIGEN THERAPEUTICS, INC.
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029806/0744 →
Assignment of Assignor's Interest Feb 13, 2013
From: HOLERS, V. MICHAEL
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029806/0793 →
Confirmatory License Jan 26, 2018
From: UNIVERSITY OF COLORADO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045169/0549 →